Velcade and vitamin C: Too much of a good thing?

被引：12

作者：

Catley, L ^{[1
]}

Anderson, KC ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02215 USA

来源：

CLINICAL CANCER RESEARCH | 2006年 / 12卷 / 01期

关键词：

D O I：

10.1158/1078-0432.CCR-05-2272

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3 / 4

页数：2

共 10 条

[1]

Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658

[2] Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system [J].

Dai, J ;

Weinberg, RS ;

Waxman, S ;

Jing, YK .

BLOOD, 1999, 93 (01) :268-277

[3] Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells [J].

Grad, JM ;

Bahlis, NJ ;

Reis, I ;

Oshiro, MM ;

Dalton, WS ;

Boise, LH .

BLOOD, 2001, 98 (03) :805-813

[4] Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion [J].

Graumlich, JF ;

Ludden, TM ;

ConryCantilena, C ;

Cantilena, LR ;

Wang, YH ;

Levine, M .

PHARMACEUTICAL RESEARCH, 1997, 14 (09) :1133-1139

[5] Vitamin C protects HL60 and U266 cells from arsenic toxicity [J].

Karasavvas, N ;

Carcamo, JM ;

Stratis, G ;

Golde, DW .

BLOOD, 2005, 105 (10) :4004-4012

[6] Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance [J].

Levine, M ;

ConryCantilena, C ;

Wang, YH ;

Welch, RW ;

Washko, PW ;

Dhariwal, KR ;

Park, JB ;

Lazarev, A ;

Graumlich, JF ;

King, J ;

Cantilena, LR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3704-3709

[7] Clinical activity of arsenic trioxide for the treatment of multiple myeloma [J].

Munshi, NC ;

Tricot, G ;

Desikan, R ;

Badros, A ;

Zangari, M ;

Toor, A ;

Morris, C ;

Anaissie, E ;

Barlogie, B .

LEUKEMIA, 2002, 16 (09) :1835-1837

[8] Vitamin C as an antioxidant: Evaluation of its role in disease prevention [J].

Padayatty, SJ ;

Katz, A ;

Wang, YH ;

Eck, P ;

Kwon, O ;

Lee, JH ;

Chen, SL ;

Corpe, C ;

Dutta, A ;

Dutta, SK ;

Levine, M .

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2003, 22 (01) :18-35

[9] Vitamin C pharmacokinetics: Implications for oral and intravenous use [J].

Padayatty, SJ ;

Sun, H ;

Wang, YH ;

Riordan, HD ;

Hewitt, SM ;

Katz, A ;

Wesley, RA ;

Levine, M .

ANNALS OF INTERNAL MEDICINE, 2004, 140 (07) :533-537

[10] Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells. [J].

Zou, W ;

Yue, P ;

Lin, N ;

He, M ;

Zhou, ZM ;

Lonial, S ;

Khuri, FR ;

Wang, BH ;

Sun, SY .

CLINICAL CANCER RESEARCH, 2006, 12 (01) :273-280

← 1 →